Effects of insulin-like growth factor-1 on retinal endothelial cell glucose transport and proliferation

J Neurochem. 2001 May;77(4):1157-67. doi: 10.1046/j.1471-4159.2001.00325.x.

Abstract

Insulin-like growth factor-1 (IGF-1) plays important roles in the developing and mature retina and in pathological states characterized by retinal neovascularization, such as diabetic retinopathy. The effects of IGF-1 on glucose transport and proliferation and the signal transduction pathways underlying these effects were studied in a primary bovine retinal endothelial cell (BREC) culture model. IGF-1 stimulated uptake of the glucose analog 2-deoxyglucose in a dose-dependent manner, with a maximal uptake at 25 ng/mL (3.3 nM) after 24 h. Increased transport occurred in the absence of an increase in total cellular GLUT1 transcript or protein. IGF-1 stimulated activity of both protein kinase C (PKC) and phosphatidylinositol-3 kinase (PI3 kinase), and both pathways were required for IGF-1-mediated BREC glucose transport and thymidine incorporation. Use of a selective inhibitor of the beta isoform of PKC, LY379196, revealed that IGF-1 stimulation of glucose transport was mediated by PKC-beta; however, inhibition of PKC-beta had no effect on BREC proliferation. Taken together, these data suggest that the actions of IGF-1 in retinal endothelial cells couple proliferation with delivery of glucose, an essential metabolic substrate. The present studies extend our general understanding of the effects of IGF-1 on vital cellular activities within the retina in normal physiology and in pathological states such as diabetic retinopathy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 3-O-Methylglucose / metabolism
  • Animals
  • Biological Transport
  • Cattle
  • Cell Division / drug effects
  • Cells, Cultured
  • Deoxyglucose / metabolism
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / metabolism
  • Enzyme Inhibitors / pharmacology
  • Glucose / metabolism*
  • Glucose Transporter Type 1
  • Indoles / pharmacology
  • Insulin-Like Growth Factor I / pharmacology*
  • Maleimides / pharmacology
  • Monosaccharide Transport Proteins / metabolism
  • Phosphatidylinositol 3-Kinases / metabolism
  • Protein Kinase C / metabolism
  • Retinal Vessels / drug effects
  • Retinal Vessels / physiology*
  • Thymidine / metabolism

Substances

  • Enzyme Inhibitors
  • Glucose Transporter Type 1
  • Indoles
  • Maleimides
  • Monosaccharide Transport Proteins
  • 3-O-Methylglucose
  • Insulin-Like Growth Factor I
  • Deoxyglucose
  • Phosphatidylinositol 3-Kinases
  • Protein Kinase C
  • Glucose
  • bisindolylmaleimide I
  • Thymidine